Connect with us

Medication

Oncology Nutrition Market Next Big Thing | Big Giants- Nestle, Sofina, Reckitt Benckiser

Published

on

Oncology Nutrition Market

Oncology Nutrition Market

Oncology Nutrition Market

Data Insights Market has published a new research publication on Oncology Nutrition Market Insights, up to 2032 that has 232 pages and is updated with tables and charts that are self-explanatory in a clear format. In the course you will discover the emerging Trends, Drivers, Restraints, Opportunities that arise by focusing on relevant market participants. The growth of the Oncology Nutrition market has been largely driven by increasing R&D spending across the globe.

Some of the key players featured in the study are:
Global Health Products Inc, Nestle, Sofina (Danone SA ), Reckitt Benckiser Group plc (Mead Johnson & Company LLC), Abbott Laboratories, Fresenius Kabi AG, Hormel Foods Corporation, Victus Inc, Meiji Holdings Company Ltd, B Braun SE.

Get a free sample PDF copy of this Survey @ https://datainsightsmarket.com/report/oncology-nutrition-market-7970/sample-report?utm_source=OpenPR&utm_medium=Suraj

Advertisement

Oncology Nutrition Report Site
The Oncology Nutrition Market size was estimated at USD 140 Million in 2023 and is expected to reach USD 300 Million by 2032, with an expected CAGR of 8.90% during the forecast period. The Oncology Nutrition market focuses on nutritional interventions aimed at helping cancer patients during their treatment and recovery process. Pharmaceutical products under this market include high-protein and high-calorie products, nutritional supplements and regular meals for customers undergoing chemotherapy or radiation, or surgery. This includes treating side effects such as nausea, loss of appetite, weight loss among others, overall health and even improving the effectiveness of treatment. Some of these include: adaptation and continuous improvement of nutritional solutions, development of nutritional practices, and focus on implementing nutrition in the cancer care system. improve the quality of treatment and the health of patients.

The named segments and market segments are highlighted below:
By Cancer Type: Head and Neck Cancer, Stomach and Colon Cancer, Blood Cancer, Breast Cancer, Lung Cancer, Other Cancers, By User: Hospitals, Home Care, Other Users.

Market Drivers:
Global Cancer Prevalence
Introduction of New Oncology Nutritional Products

Market Trends:
Lung Cancer Expected to See Health Growth During Forecast

Restrictions:
High Cost of Primary Nutrition Products for Oncology

Advertisement

What can be assessed in the Oncology Nutrition Market Study?
• Gain Market Insights
• Identify Growth Opportunities
• Analyze and Evaluate the Global Oncology Nutrition Market by Identifying Investments across Different Industry Verticals.
• Understand the Trends That Will Drive Future Changes in Oncology Nutrition
• Understand the Competitive Landscape
– Track Right Markets
– Define Fair Prices

Regions covered are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa

Country Distribution: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.

Have Any Query Regarding Global Oncology Nutrition Market Report, Ask Our Experts@ https://datainsightsmarket.com/report/oncology-nutrition-market-7970/enquiry-before-buy?utm_source=OpenPR&utm_medium=Suraj

Strategic Points Included in Global Oncology Nutrition Market News List:
Chapter 1: Introduction, product market driving force Objectives and Statistical analysis of the Oncology Nutrition market
Chapter 2: Executive Summary – basic information of Oncology Nutrition Market.
Chapter 3: Market Dynamics- Drivers, Trends and Challenges and Opportunities in Oncology Nutrition.
Chapter 4: Developing Oncology Nutrition Market Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displays by Type, User and Region/Country 2019-2023
Chapter 6: To assess the leading manufacturers of Oncology Nutrition market with Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile.
Chapter 7: To analyze the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these different regions (2024-2032)
Chapter 8 & 9: Showing Appendix, Method and Data Source

Advertisement

In conclusion, Oncology Nutrition Market is a valuable source of guidance for both individuals and companies.

Get Up to 30% Discount on this Premium Account: @ https://datainsightsmarket.com/report/oncology-nutrition-market-7970/request-discount?utm_source=OpenPR&utm_medium=Suraj

Thanks for reading this article; You can also find an individual chapter of the intelligence section or regional intelligence report version such as North America, Middle East, Africa, Europe or LATAM, Southeast Asia.

Contact us:
Craig Francis (PR & Marketing Manager)
Data Insights Market
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: (+1 2017933837, +44 20 7097 9277)
sales@datainsightsmarket.com

About the Author:
Data Insights Market is a global leader in the Market Research Industry providing proven B2B research to Fortune 500 companies on emerging high growth opportunities that will impact more than 80% of their revenue. global companies.
Our analyst follows a high-growth study with statistics and in-depth analysis of market trends and dynamics that provide a comprehensive view of the industry. We follow a comprehensive approach to research as well as important information related to the industry and market dynamics to produce the best value for our clients. We provide reliable sources of primary and secondary data, our analysts and consultants find informative and actionable information that suits our clients’ business needs. Research studies help clients achieve various market objectives from global expansion to supply chain optimization and from competitive profiling to M&As.

Advertisement

This announcement was published on OpenPR.

#Oncology #Nutrition #Market #Big #Big #Giants #Nestle #Sofina #Reckitt #Benckiser

Medication

5WPR Expands Health and Wellness Divide with New Focus on Functional Nutrition

Published

on

By

5WPR Expands Health and Wellness Divide with New Focus on Functional Nutrition

Strengthening Capacity to Support Growing Demand in the Functional Food Sector

NEW YORK, December 3, 2024 /PRNewswire/ — 5WPR, one of America’s leading and largest independent PR firms, is proud to announce the expansion of its Health & Wellness division to include focusing on Functional Nutrition. This strategic move reflects 5W’s commitment to staying ahead of industry trends and evolving its services to meet the needs of this rapidly changing market.

5W Brand (PRNewsfoto/5W Public Relations)
5W Brand (PRNewsfoto/5W Public Relations)

With increasing consumer interest in functional foods, brands are seeking expert guidance to differentiate themselves in a competitive market. In response, 5WPR has expanded its services to cover key areas within the nutrition industry, including gut health, supplements and functional drinks, performance and sports nutrition, protein powder, probiotics, weight management, collagen peptides, dietary powder, functional mushrooms. , nutrition, and pet health.

Functional nutrition has become an influence in the field of health and wellness, fueled by increased consumer awareness and demand for products that provide more than basic nutritional benefits. According to the latest data from Open PR, gut health products alone are estimated to grow by approximately 8% annually between 2024 and 2031. Additionally, the Food Institute is report that e-commerce has emerged as the fastest growing channel for supplements in 2023, an increase of 9.5%, highlighting the importance of a strong online presence. Performance nutrition has also seen significant growth, with categories such as hydration and electrolytes increasing by 52.2%, and creatine sales increasing by an impressive 114.4%, according to the New Hope Network.

«The functional nutrition market is not only growing; it is defining the health and wellness industry,» he said. Ilisa WirginManaging Partner and EVP of 5WPR’s Health & Wellness and Beauty division. «Consumers are looking for products that improve their overall well-being, improve performance, and support recovery, which makes it an exciting and exciting segment. Our expanded focus will help us helping customers in this area to grow their product profiles, align with their target audience, and deliver meaningful results.»

Advertisement

5WPR’s track record in health and wellness includes working with some of the most recognized brands in fitness, nutrition, and personal care. The agency’s expertise in media relations, influencer partnerships, thought leadership, digital strategy, and affiliate marketing ensures that clients in the nutrition space receive structured, comprehensive, and measurable support.

#5WPR #Expands #Health #Wellness #Divide #Focus #Functional #Nutrition

Continue Reading

Medication

Lady Gabriella’s husband ‘killed himself after taking antidepressants’

Published

on

By

Thomas Kingston and Lady Gabriella Kingston after their wedding at St George's Chapel in Windsor in 2019.

Your support helps us tell the story

From reproductive rights to climate change to Big Tech, The Independent is breaking new ground as the story unfolds. Whether it’s investigating Elon Musk’s pro-Trump PAC funding or presenting our latest article, ‘The A Word’, which shines a light on American women fighting for reproductive rights, we know how How important is clarity in messages.

At such a critical time in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to talk to both sides of the story.

The Independent is trusted by Americans across all political lines. And unlike many other quality publications, we choose not to block Americans from reporting and reviewing through paywalls. We believe that quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Lady Gabriella Kingston’s husband took his own life after taking anti-depressants prescribed by his doctor, a coroner has said.

Advertisement

Thomas Kingston, who married Prince and Princess Michael of Kent’s daughter at Windsor Castle in 2019, died of a head injury and a gun was found next to his body on March 25 at his parents’ home in the Cotswolds.

At an inquest into her death held at Gloucestershire Coroner’s Court on Tuesday, Lady Gabriella, 43, asked people to be warned about the side effects of drugs used to treat mental health conditions or she feared people would many may die.

The inquest was told that the 45-year-old fundraiser had been given sertraline, a drug used to treat depression, and zopiclone, a sleeping pill, by a doctor at the Royal Mews Surgery, Buckingham Palace’s staff-run practice. of the palace. , after complaining of trouble sleeping after stress at work.

Mr Kingston went back to surgery saying they were not making him feel better, and his doctor switched him from sertraline to citalopram, a similar drug.

Thomas Kingston and Lady Gabriella Kingston after their wedding at St George's Chapel in Windsor in 2019.

Advertisement
Thomas Kingston and Lady Gabriella Kingston after their wedding at St George’s Chapel in Windsor in 2019. (PA Archives)

In the first days of his death, Mr. Kingston had stopped taking medication, and toxicology tests showed caffeine and a small amount of zopiclone in his system.

In a statement read out by Katy Skerrett, chief minister of Gloucestershire, Lady Gabriella, 43, said: «[Work] it has been a challenge for her over the years but I highly doubt it would have made her suicidal, and she seemed to have improved a lot.

If there was something that was bothering him, I’m sure he would have said that he was struggling a lot.

The fact that he committed suicide in the home of his beloved parents suggests that the decision was the result of a sudden impulse.

He said he believed her death «may have been precipitated» by an adverse reaction to medication she had started, and then stopped, taking in the weeks leading up to her death.

Advertisement

«In the absence of any evidence of propensity, it seems very likely to me that she had a bad reaction to the pills that made her take her own life,» Lady Gabriella said.

Thomas Kingston and Lady Gabriella Kingston arrive at the Thanksgiving service for Prince Philip at Westminster Abbey in 2022.

Thomas Kingston and Lady Gabriella Kingston arrive at the Thanksgiving service for Prince Philip at Westminster Abbey in 2022. (AFP via Getty Images)

«I believe that anyone who takes pills like these should be warned about the side effects to prevent future deaths.

If this can happen to Tom, it can happen to anyone.

In his final weeks, Mrs Gabriella said, her husband «seemed normal», except for the morning after he first took zopiclone, which she said made him seem «he he’s a bit confused».

Advertisement

In his statement, he described their marriage as one of «deep love and trust» and said he never gave any suicidal thoughts to himself or others.

He also said he was deeply affected by his friend’s suicide and «the negative impact it had on other people’s loved ones».

Miss Gabriella, whose wedding to Mr Kingston included Queen Elizabeth II and the late Duke of Edinburgh among the guests, wept as she sat in the coroner’s court as her statement was read.

Thomas Kingston died of a head injury and a gun was found next to his body on February 25 at his parents' home in the Cotswolds.

Thomas Kingston died of a head injury and a gun was found next to his body on February 25 at his parents’ home in the Cotswolds. (PA Archives)

Wrapping up the story, Ms Skerrett said: «Mr Kingston took his own life with a self-inflicted gunshot wound to the head.

Advertisement

«The evidence of his wife, family and business partner all support the lack of intent to kill himself.

He was suffering from the side effects of the medicine he had just been given.»

He said he intends to make a report on the prevention of future deaths, which will be sent to medical societies.

Mr. Kingston’s father, William Martin Kingston, wept as he described finding his son in the locked bathroom of the annexe, having used a doorknob to break the door.

He told the court that his son has always had a strong, unstable character, as he previously suffered from pain that left him needing help to climb the stairs.

Advertisement

She told the coroner that before her son’s death there did not appear to be any evidence of suicide, and there was no will, describing the process as «reckless.» very» who was «out of shape».

Dr David Healy, a psychiatrist who gave evidence at the hearing, said zopiclone could also cause anxiety, while sertraline and citalopram were both serotonin reuptake inhibitors (SSRIs), and while exactly the same.

Dr Healy said Mr Kingston’s complaints that sertraline continued to cause him anxiety was a sign SSRIs «didn’t suit him», and he should not have been prescribed the same thing again.

He said the guidelines and labels for SSRIs were not clear enough about using the drug first, or what the effect would be when switching from one to another.

He said: «We need a clearer statement that these drugs can cause people to kill themselves who would otherwise not kill themselves.

Advertisement

Speaking to the doctor, Martin Porter, the family’s adviser, said: «The family is not to blame (her doctor) Dr Naunton Morgan, he worked like a good doctor.

But the question is whether there is enough advice to doctors about SSRIs.

#Lady #Gabriellas #husband #killed #antidepressants

Continue Reading

Medication

AlayaCare’s Cloud-Based EHR Platform Onboards Home Care Benefits of the Home Care Center

Published

on

By

AlayaCare's Cloud-Based EHR Platform Onboards Home Care Benefits of the Home Care Center

AlayaCare Inc.
AlayaCare Inc.

AlayaCare’s Cloud-Based EHR Platform Onboards Home Care Benefits of the Home Care Center

AlayaCare has successfully partnered with Care Advantage, the largest home health care provider in the mid-Atlantic, to implement a sustainable approach to improving care delivery in 50+ locations.
AlayaCare has successfully partnered with Care Advantage, the largest home health care provider in the mid-Atlantic, to implement a sustainable approach to improving care delivery in 50+ locations.

NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) — AlayaCare, a global technology platform for home and community care, is pleased to announce today the successful implementation of Care Advantage, Inc.

Care Advantage, Inc. is the largest independent home health provider in the mid-Atlantic. The company provides personal services, home care and home health services throughout Virginia, Maryland, Delaware, North Carolina and Washington DC.

Care Advantage’s leadership recognized AlayaCare’s ability to provide a risk-free, user-friendly solution that could grow with the company. The decision to collaborate with AlayaCare was made after an extensive selection process that considered the opinions of experts from its internal teams, emphasizing the importance of a holistic approach to choosing a technology partner.

«We were looking for a partner, not just a vendor, who could help us build and transform our system over time,» said Tim Hanold, CEO of Care Advantage. «AlayaCare’s commitment to working together and creating a true partnership were key factors in our final decision.»

Despite the challenges presented by the published timeline and coverage of more than 50 locations, both teams worked closely to customize the system to meet Care Advantage’s needs.

Advertisement

«Implementing a system of this size in such a short period of time was no small feat,» said Jaron Clay, VP of Integrations. «The speed of the rollout was only possible with good coordination and both groups are committed to having Care Advantage running smoothly and feeling the benefits of the new system as soon as possible.»

The move to AlayaCare underscores Care Advantage’s commitment to innovation and excellence in home care, ensuring clients and their families receive the best possible care and support. As a highly data-driven and growth-focused company, the flexibility of AlayaCare’s platform enables large operations to enter new markets while maintaining a high level of customer care. own and create new opportunities for its custodians.

«There is a shared understanding and vision between us and the AlayaCare team,» said Tim Hanold. «They support our unwavering commitment to excellence in the classroom and are part of the reason we chose them. We feel this is the platform to take us to that level. We are delighted to have AlayaCare as a partner our technology,» he concluded. «Together, we’re setting new standards for home care.»

#AlayaCares #CloudBased #EHR #Platform #Onboards #Home #Care #Benefits #Home #Care #Center

Advertisement
Continue Reading

Trending

Copyright © 2017 Zox News Theme. Theme by MVP Themes, powered by WordPress.